Professional paper
The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm
Duška Glavaš
; University Hospital Centre Split, Split, Croatia
Full text: croatian pdf 48 Kb
page 24-26
downloads: 247
cite
APA 6th Edition
Glavaš, D. (2012). The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica, 7 (1-2), 24-26. Retrieved from https://hrcak.srce.hr/77047
MLA 8th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica, vol. 7, no. 1-2, 2012, pp. 24-26. https://hrcak.srce.hr/77047. Accessed 17 May 2024.
Chicago 17th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica 7, no. 1-2 (2012): 24-26. https://hrcak.srce.hr/77047
Harvard
Glavaš, D. (2012). 'The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm', Cardiologia Croatica, 7(1-2), pp. 24-26. Available at: https://hrcak.srce.hr/77047 (Accessed 17 May 2024)
Vancouver
Glavaš D. The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica [Internet]. 2012 [cited 2024 May 17];7(1-2):24-26. Available from: https://hrcak.srce.hr/77047
IEEE
D. Glavaš, "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm", Cardiologia Croatica, vol.7, no. 1-2, pp. 24-26, 2012. [Online]. Available: https://hrcak.srce.hr/77047. [Accessed: 17 May 2024]
Full text: english pdf 48 Kb
page 24-26
downloads: 231
cite
APA 6th Edition
Glavaš, D. (2012). The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica, 7 (1-2), 24-26. Retrieved from https://hrcak.srce.hr/77047
MLA 8th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica, vol. 7, no. 1-2, 2012, pp. 24-26. https://hrcak.srce.hr/77047. Accessed 17 May 2024.
Chicago 17th Edition
Glavaš, Duška. "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm." Cardiologia Croatica 7, no. 1-2 (2012): 24-26. https://hrcak.srce.hr/77047
Harvard
Glavaš, D. (2012). 'The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm', Cardiologia Croatica, 7(1-2), pp. 24-26. Available at: https://hrcak.srce.hr/77047 (Accessed 17 May 2024)
Vancouver
Glavaš D. The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm. Cardiologia Croatica [Internet]. 2012 [cited 2024 May 17];7(1-2):24-26. Available from: https://hrcak.srce.hr/77047
IEEE
D. Glavaš, "The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm", Cardiologia Croatica, vol.7, no. 1-2, pp. 24-26, 2012. [Online]. Available: https://hrcak.srce.hr/77047. [Accessed: 17 May 2024]
Abstract
In the treatment of chronic heart failure (HF) as the major problem of modern medicine, there is a need to develop new therapeutic approaches, so each new medicamentous intervention undertaken in respect to adverse pathophysiological course of this disease is worth cardiologist’s attention. The trial SHIFT (Systolic Heart failure treatment with the IF inhibitor ivabradine Trial) which investigated the effect of adding ivabradine to patients with HF who were previously treated according to the guidelines, has been published. SHIFT has confirmed that further slowdown of the heart rate by ivabradine may increase the benefits of neurohormonal blockade in chronic HF. Some international societies of cardiology reacted to the results of this trial by adapting the existing national guidelines or publicizing the consensus, which firmly define the place ivabradine in treating patients with HF.
Keywords
heart failure; heart rate; , ivabradine
Hrčak ID:
77047
URI
https://hrcak.srce.hr/77047
Publication date:
26.1.2012.
Article data in other languages:
croatian
Visits: 1.080
*
